Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 3
2016 4
2017 5
2018 9
2019 11
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
Verberk IMW, Slot RE, Verfaillie SCJ, Heijst H, Prins ND, van Berckel BNM, Scheltens P, Teunissen CE, van der Flier WM. Verberk IMW, et al. Among authors: Verfaillie SCJ. Ann Neurol. 2018 Nov;84(5):648-658. doi: 10.1002/ana.25334. Epub 2018 Oct 4. Ann Neurol. 2018. PMID: 30196548 Free PMC article.
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ; Amyloid PET Study Group, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen HJ, Landau SM, Villemagne VL, Rowe CC, Lee DY, Na DL, Seo SW, Sarazin M, Roe CM, Sabri O, Barthel H, Koglin N, Hodges J, Leyton CE, Vandenberghe R, van Laere K, Drzezga A, Forster S, Grimmer T, Sánchez-Juan P, Carril JM, Mok V, Camus V, Klunk WE, Cohen AD, Meyer PT, Hellwig S, Newberg A, Frederiksen KS, Fleisher AS, Mintun MA, Wolk DA, Nordberg A, Rinne JO, Chételat G, Lleo A, Blesa R, Fortea J, Madsen K, Rodrigue KM, Brooks DJ. Ossenkoppele R, et al. Among authors: Verfaillie SC. JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669. JAMA. 2015. PMID: 25988463 Free PMC article.
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.
Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, Dardiotis E, Guillo-Benarous F, Hampel H, Kochan NA, Lista S, Luck T, Maruff P, Molinuevo JL, Kornhuber J, Reisberg B, Riedel-Heller SG, Risacher SL, Roehr S, Sachdev PS, Scarmeas N, Scheltens P, Shulman MB, Saykin AJ, Verfaillie SCJ, Visser PJ, Vos SJB, Wagner M, Wolfsgruber S, Jessen F; Alzheimer's Disease Neuroimaging Initiative; DESCRIPA working group; INSIGHT-preAD study group; SCD-I working group, van der Flier WM. Slot RER, et al. Among authors: Verfaillie SCJ. Alzheimers Dement. 2019 Mar;15(3):465-476. doi: 10.1016/j.jalz.2018.10.003. Epub 2018 Dec 13. Alzheimers Dement. 2019. PMID: 30555032 Free PMC article. Clinical Trial.
Dietary Patterns Are Related to Clinical Characteristics in Memory Clinic Patients with Subjective Cognitive Decline: The SCIENCe Project.
Wesselman LMP, Doorduijn AS, de Leeuw FA, Verfaillie SCJ, van Leeuwenstijn-Koopman M, Slot RER, Kester MI, Prins ND, van de Rest O, de van der Schueren MAE, Scheltens P, Sikkes SAM, van der Flier WM. Wesselman LMP, et al. Among authors: Verfaillie SCJ. Nutrients. 2019 May 11;11(5):1057. doi: 10.3390/nu11051057. Nutrients. 2019. PMID: 31083522 Free PMC article.
Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results.
Slot RER, Verfaillie SCJ, Overbeek JM, Timmers T, Wesselman LMP, Teunissen CE, Dols A, Bouwman FH, Prins ND, Barkhof F, Lammertsma AA, Van Berckel BNM, Scheltens P, Sikkes SAM, Van der Flier WM. Slot RER, et al. Among authors: Verfaillie SCJ. Alzheimers Res Ther. 2018 Aug 7;10(1):76. doi: 10.1186/s13195-018-0390-y. Alzheimers Res Ther. 2018. PMID: 30081935 Free PMC article.
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project.
Timmers T, Ossenkoppele R, Verfaillie SCJ, van der Weijden CWJ, Slot RER, Wesselman LMP, Windhorst AD, Wolters EE, Yaqub M, Prins ND, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BNM. Timmers T, et al. Among authors: Verfaillie SCJ. Neurobiol Aging. 2019 Jul;79:50-58. doi: 10.1016/j.neurobiolaging.2019.02.020. Epub 2019 Mar 8. Neurobiol Aging. 2019. PMID: 31026622 Free article.
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project.
van Maurik IS, Slot RER, Verfaillie SCJ, Zwan MD, Bouwman FH, Prins ND, Teunissen CE, Scheltens P, Barkhof F, Wattjes MP, Molinuevo JL, Rami L, Wolfsgruber S, Peters O, Jessen F, Berkhof J, van der Flier WM; Alzheimer’s Disease Neuroimaging Initiative. van Maurik IS, et al. Among authors: Verfaillie SCJ. Alzheimers Res Ther. 2019 Apr 16;11(1):33. doi: 10.1186/s13195-019-0487-y. Alzheimers Res Ther. 2019. PMID: 30987684 Free PMC article.
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum.
Timmers T, Ossenkoppele R, Wolters EE, Verfaillie SCJ, Visser D, Golla SSV, Barkhof F, Scheltens P, Boellaard R, van der Flier WM, van Berckel BNM. Timmers T, et al. Among authors: Verfaillie SCJ. Alzheimers Res Ther. 2019 Jul 4;11(1):60. doi: 10.1186/s13195-019-0510-3. Alzheimers Res Ther. 2019. PMID: 31272512 Free PMC article.
Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease.
Verfaillie SCJ, Pichet Binette A, Vachon-Presseau E, Tabrizi S, Savard M, Bellec P, Ossenkoppele R, Scheltens P, van der Flier WM, Breitner JCS, Villeneuve S; PREVENT-AD Research Group. Verfaillie SCJ, et al. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 May;3(5):463-472. doi: 10.1016/j.bpsc.2017.11.012. Epub 2017 Dec 14. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29735156
Test-retest repeatability of [18F]Flortaucipir PET in Alzheimer's disease and cognitively normal individuals.
Timmers T, Ossenkoppele R, Visser D, Tuncel H, Wolters EE, Verfaillie SC, van der Flier WM, Boellaard R, Golla SS, van Berckel BN. Timmers T, et al. Among authors: Verfaillie SC. J Cereb Blood Flow Metab. 2019 Oct 1:271678X19879226. doi: 10.1177/0271678X19879226. Online ahead of print. J Cereb Blood Flow Metab. 2019. PMID: 31575335 Free article.
32 results
Jump to page
Feedback